Lunai Bioworks (LNAI) EPS (Basic) Growth (5y) (2016 - 2026)
Lunai Bioworks (LNAI) EPS (Basic) Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.81 Bn | 131.96 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.56 Bn | 78.56 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.72 Bn | 60.53 Bn | 1.37 Bn |
| 4 | Moderna | 58.75 Bn | 53.61 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.76 Bn | 28.45 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.59 Bn | 10.19 Bn | 668.28 Mn |
| 8 | Insmed | 27.63 Bn | 26.47 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.24 Bn | 26.40 Bn | - |
| 10 | Lunai Bioworks | 7.03 Mn | 3.87 Mn | 20,942.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.65% |
| Dec 31, 2025 | 33.33% |
| Sep 30, 2025 | 21.60% |
| Jun 30, 2025 | -53.99% |
| Mar 31, 2025 | 3.91% |
| Dec 31, 2024 | 5.04% |
| Sep 30, 2024 | -31.06% |
| Jun 30, 2024 | -49.44% |
| Mar 31, 2024 | -45.56% |
| Dec 31, 2023 | 31.12% |
| Sep 30, 2023 | -71.19% |
| Jun 30, 2023 | -34.58% |
| Mar 31, 2023 | 8.32% |
| Dec 31, 2022 | -0.65% |
| Sep 30, 2022 | -51.01% |
| Jun 30, 2022 | -157.85% |
| Mar 31, 2022 | -35.47% |
| Dec 31, 2021 | -5.48% |
| Sep 30, 2021 | -19.10% |
| Jun 30, 2021 | -23.56% |